Şeyhmus Kaya

Şeyhmus Kaya

Auto-generated profile, based on publicly available information

Şeyhmus Kaya

Eskisehir City Hospital

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2022 in Journal of Turkish Sleep Medicine
Verified
Journal Article
Closed access
DŞDilek Şayık
Dilek Şayık
AAAyfer Açıkgöz
Ayfer Açıkgöz
ŞKŞeyhmus Kaya
Şeyhmus Kaya

1 January 2020 in Indian Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
FKFiliz baloğlu kaya
Filiz baloğlu kaya
CKCaglar Kuas
Caglar Kuas
EOEngin Ozakin
Engin Ozakin
MKMuhammed Evvah Karakilic
Muhammed Evvah Karakilic
SKSeyhmus Kaya
Seyhmus Kaya
There are a limited number of studies on postoverdose clinical findings of mirtazapine in the literature. Our case presented an unlikely junctional rhythm, which we have not seen in the previous studies, in a patient who had bradycardia and hypotension following mirtazapine intake. A 37-year old male was admitted to the emergency department (ED) after his suicide attempt with 300 mg PO of mirtazapine tablets. He took the drug 2 h prior to his ED visit. He did not have any complaints after the mirtazapine intake. His complete physical examination and electrocardiography (ECG) revealed no pathological findings. He was observed in the ED. The results were in the normal range in his blood test and he has 0 mg/dl of blood ethanol. He experienced dizziness after 5 h and 30 min. The blood pressure was 60/30 mmHg. The heart rate was 34 beats/min. The simultaneous ECG showed junctional bradycardia. 0.5 mg atropine IV was given two times at intervals. Norepinephrine infusion was initiated after normal saline therapy. Forty-five minutes later, he did not have any clinically significant complaint. There are no pathological findings in his follow-up ECG and physical examination. He was discharged of his own accord 10 h after his ED admission. His initial mirtazapine level was 145 ng/ml when he came to the ED. Mirtazapine was known to have a safe cardiac profile both for regular dose and overdose. However, physicians should consider that it might induce a life-threatening bradyarrhythmia.

14 October 2025 in Annals of Noninvasive Electrocardiology
Verified
Journal Article
Open access
GYGoknur Yildiz
Goknur Yildiz
OYOzge Turgay Yildirim
Ozge Turgay Yildirim
ŞKŞeyhmus Kaya
Şeyhmus Kaya
FAFatih Alper Ayyildiz
Fatih Alper Ayyildiz
CYCan Gökay Yildiz
Can Gökay Yildiz
Background: Iron deficiency anemia (IDA) is a common global health issue affecting over two billion people and is associated with cardiovascular complications. Electrocardiographic (ECG) abnormalities may reflect cardiac involvement in IDA. The Morphology‐Voltage‐P wave Duration (MVP) score, which assesses P‐wave duration, voltage, and morphology, is linked to atrial fibrillation (AF) risk. This study aimed to investigate the relationship between IDA and MVP score to evaluate its potential in cardiac risk assessment. Methods: A prospective study was conducted between January 1 and June 30, 2024, at a tertiary hospital. It included 241 IDA patients and 204 healthy controls. All participants underwent ECG and echocardiography. MVP scores were calculated, and left atrial (LA) diameter and left ventricular ejection fraction (LVEF) were recorded. Results: MVP scores were significantly higher in the IDA group compared to controls ( p < 0.001). P‐wave morphology and voltage were notably altered in IDA patients ( p < 0.001). LA diameters were larger, and LVEF values were lower in the IDA group ( p < 0.001). MVP scores positively correlated with LA size and negatively with LVEF. Additionally, IDA patients had higher heart rates and lower diastolic blood pressure ( p < 0.001). Conclusions: IDA is associated with increased MVP scores, suggesting possible atrial remodeling and higher AF risk. The MVP score may serve as a non‐invasive tool for cardiovascular risk stratification in IDA patients. Further research is needed to assess the impact of IDA treatment on ECG parameters and arrhythmia risk.

28 June 2026 in Anatolian Journal of Emergency Medicine
Verified
Journal Article
Closed access
RÇResul Çinpolat
Resul Çinpolat
ŞKŞeyhmus Kaya
Şeyhmus Kaya
VÖVehbi Özaydın
Vehbi Özaydın
BYBanu Karakuş Yılmaz
Banu Karakuş Yılmaz
Aim: Intramuscular injections are among the most frequently performed procedures in daily emergency department practice. Although these interventions are generally regarded as low risk, considerable variation exists in how informed consent is obtained in routine clinical settings. With the most recent legal amendment, the possibility of obtaining informed consent electronically has been incorporated into legislation; however, no clear framework has yet been defined regarding its implementation. This study aimed to examine current informed consent practices for intramuscular injections in emergency departments, the challenges encountered by physicians, and their views on electronic informed consent.Material and Methods: This study was designed as a descriptive, cross-sectional survey. A 16-item online questionnaire developed by the research team was distributed nationwide to physicians working in emergency departments through Emergency Medicine Association of Türkiye. The survey addressed participants’ professional characteristics, approaches to obtaining informed consent for intramuscular injection procedures, views on written consent, awareness regarding the legal proof of consent, and opinions on electronic consent practices. Data were collected between June 30, 2025, and January 1, 2026.Results: The minimum target sample size for the study was determined to be 384, and a total of 409 emergency physicians participated in the study. The median age of participants was 31 years (IQR 27–39), and the median duration of emergency department experience was 4.5 years (IQR 1.4–12.0). Although 77.8% of participants stated that written informed consent should be obtained for intramuscular injections, only 32.5% reported routinely obtaining written consent in practice. Among those who reported obtaining written consent, only 34.6% indicated that they could easily access previously obtained consent records when needed. Most participants (73.1%) stated that, in the event of a legal dispute related to an intramuscular injection, the burden of proof would rest with the healthcare professional and/or the healthcare institution. The most commonly reported difficulties in obtaining written consent were high patient volume and limited time. Overall, 77.5% of participants considered electronic informed consent to be a more practical option. The most frequently preferred electronic method was providing consent by signing with an electronic pen on a touch-screen monitor installed in the examination room.Conclusion: This study demonstrates that, in emergency departments, obtaining written informed consent for intramuscular injection procedures remains limited in routine practice and is associated with challenges in documentation and traceability. Given the high workload and time constraints inherent to emergency care, electronic informed consent—if appropriately designed—may facilitate practical implementation for emergency physicians. In addition, electronically documented consent may represent a valuable option for enhancing legal security.

26 August 2026 in OSMANGAZİ JOURNAL OF MEDICINE
Verified
Journal Article
Closed access
RARıdvan Alagöz
Rıdvan Alagöz
NANurdan Acar
Nurdan Acar
EKEvvah Karakılıç
Evvah Karakılıç
EOEngin Ozakin
Engin Ozakin
ŞKŞeyhmus Kaya
Şeyhmus Kaya
MCMustafa Emin Canakci
Mustafa Emin Canakci
In this study, we sought to determine the consistency of symptoms in patients admitted to three high-volume emergency departments with a diagnosis of COVID-19 with the standard definition published by the Turkish Ministry of Health, and to examine the relationship between symptom type and clinical outcomes. This multicentre, retrospective, observational study included adult patients aged 18 years and over who tested positive for SARS-CoV-2 by RT-PCR in the emergency departments of three hospitals between 11 March and 31 December 2020. Presentation symptoms were classified as typical or atypical in accordance with the national COVID-19 guidelines dated 7 December 2020. Demographic characteristics, vital signs, laboratory results, comorbidities and clinical outcomes were compared between the two groups. A total of 5,274 patients were enrolled; 2,763 (52.4%) were male, and the median age was 63 years. Of these, 4,262 (80.8%) had typical and 1,012 (19.2%) had atypical presentations. Dyspnea was the leading complaint (38.7%), followed by cough (29.9%) and fatigue (20.6%). Patients in the typical group were older (median 64 vs. 60 years, p<0.001), had lower oxygen saturation (90% vs. 91%, p<0.001), and demonstrated higher inflammatory markers including CRP, D-dimer, LDH, and ferritin. Intensive care unit admission was more frequent in the typical group (10.1% vs. 3.2%, p<0.001), as was in-hospital mortality (10.5% vs. 3.0%, p<0.001). Approximately one in five COVID-19 patients presented to the ED with atypical complaints. It should be noted that atypical or asymptomatic patients in terms of clinical course may be missed with symptom-based screening alone. Patients presenting with typical symptoms, particularly those with dyspnea and underlying comorbidities, had considerably worse outcomes and warrant close monitoring.